Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

New tests detect finasteride and dutasteride in urine quickly and easily.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Finasteride negatively affects fish reproduction and gonadal development.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

5ARI treatment improves hair growth in older men with minimal side effects.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.